Company Active LTD

Company profile

IQ Healthtech Limited

iQ HealthTech - iQemo chemotherapy e-prescribing system

Manage the chemotherapy treatment cycle more safely, more efficiently, and from almost any internet-connected device. iQemo delivers the end-to-end electronic administration and recording of SACT for any organisation providing cancer treatment.

CRN
07684840
Founded
2011
Age
15

Overview

Legal name
IQ HEALTHTECH LIMITED
Region
South West England
Registered address
LYTCHETT HOUSE, 13 FREELAND PARK
WAREHAM ROAD
POOLE
DORSET
ENGLAND
BH16 6FA
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

ABRIDGEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
21

Company events

Reference milestones and recent Companies House filing stream events.

9 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

09 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

03 Jul
2026

Accounts With Accounts Type Unaudited Abridged

Accounts Analysed

AA | Transaction MzUzMDMxNjg5MWFkaXF6a2N4

Published 03 Jul 2026 11:33

25 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

25 Feb
2025

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQ1NjM0NTY0MWFkaXF6a2N4

Published 25 Feb 2025 14:43

25 Feb
2025

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQ1NjM0NTQ4OWFkaXF6a2N4

Published 25 Feb 2025 14:42

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

25 Sep
2024

Accounts With Accounts Type Unaudited Abridged

Accounts Analysed

AA | Transaction MzQzNzE5OTkwMWFkaXF6a2N4

Published 25 Sep 2024 12:59

28 Jun
2011

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2019
Funded years
2019
Age at first award
7 years

Projects

2019 Collaborative R&D

Affinity: Home blood count monitoring for personalised delivery of cancer therapy

1 Feb 2019 to 31 Jul 2021

Awarded
£38,474
Total cost £85,498

"50% of people are expected to get cancer at some point in their life. Even with new therapies, many patients will experience unwanted side effects from their treatment that may range from minor psychological issues through to life threatening infections. With cancer patients spending a significant amount of time outside of healthcare facilities, it becom...

Product types

Collaborative R&D